Related Experiment Video
Updated: May 11, 2026

09:52
Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
17.1K
Workflow and Short-Term Functional Outcomes in Simultaneous Acute Code Stroke Activation and Stroke Reperfusion
Robert Joseph Sarmiento1, Amanda Wagner1, Asif Sheriff2
1Department of Medicine, University of Alberta, Edmonton, AB T6G2B7, Canada; rsarmien@ualberta.ca (R.J.S.).
Neurosci
|November 1, 2024
Summary
Simultaneous acute code stroke activation (ACSA) is common in reperfusion therapy patients. While it prolonged door-to-CT times, it did not impact 90-day home time, suggesting workflow optimization is key.
Area of Science:
- Emergency Medicine
- Neurology
- Healthcare Management
Background:
- Simultaneous acute code stroke activation (ACSA) presents a growing challenge in emergency departments.
- The impact of simultaneous ACSA on patient workflow and outcomes is not well understood.
- Optimizing emergency care for acute stroke patients requires evaluating complex activation scenarios.
Purpose of the Study:
- To assess the effect of simultaneous ACSA on workflow metrics, specifically door-to-CT (DTC) time.
- To evaluate the impact of simultaneous ACSA on functional outcome, measured as home time at 90 days.
- To determine the frequency of simultaneous ACSA in patients receiving acute reperfusion therapies.
Main Methods:
- Retrospective analysis of 2605 acute code stroke activations.
- Defined simultaneous ACSA based on timing relative to reperfusion therapies (thrombolysis, thrombectomy) or no reperfusion.
- Assessed workflow using door-to-CT (DTC) time and functional outcome using 90-day home time.
Main Results:
- 33% of ACSA events were simultaneous, with 40.4% of patients receiving reperfusion therapy undergoing simultaneous treatments.
- Grade 3 simultaneous ACSA was associated with significantly prolonged median DTC times (18 vs. 15 minutes).
- No significant difference in median 90-day home time was observed between simultaneous and non-simultaneous ACSA patients.
Conclusions:
- Simultaneous ACSA is a frequent occurrence in patients undergoing acute reperfusion therapies.
- While simultaneous ACSA can delay diagnostic imaging (DTC), it does not appear to negatively affect long-term functional outcomes (90-day home time).
- Implementing optimal workflows in high-volume stroke centers may mitigate the clinical and system burdens associated with simultaneous ACSA.

